Data sets, elements and combos paramaterized

This view should be used for custom for validation only.

dataset dataelement shortname code dataelementuid dataelementdesc categoryoptioncombo categoryoptioncombocode categoryoptioncombouid
Host Country Targets: Narratives (USG) FY2020 AGYW (N, DSD_NARRATIVE) TARGET: DREAMS AGYW (N, DSD_NARRATIVE) TARGET AGYW_N_DSD_NARRATIVE_TARGET OhO0kEONXyn default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 CXCA_SCRN (N, DSD_NARRATIVE) TARGET: On ART screened for cervical cancer. CXCA_SCRN (N, DSD_NARRATIVE) TARGET CXCA_SCRN_N_DSD_NARRATIVE_TARGET z9j1ZMcTFBH Target Number of HIV-positive women on ART screened for cervical cancer default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 CXCA_SCRN (N, TA_NARRATIVE) TARGET: On ART screened for cervical cancer. CXCA_SCRN (N, TA_NARRATIVE) TARGET CXCA_SCRN_N_TA_NARRATIVE_TARGET fbprxLiXrsl Target Number of HIV-positive women on ART screened for cervical cancer default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 DIAGNOSED_NAT (N, NAT_JUSTIFICATION) TARGET: HIV Known Status DIAGNOSED_NAT (N, NAT_JUSTIFICATION) TARGET DIAGNOSED_NAT_N_NAT_JUSTIFICATION_TARGET DjD5K1XeJqx Number of people living with HIV who know their status default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 DIAGNOSED_NAT (N, NAT_SOURCE) TARGET: HIV Known Status DIAGNOSED_NAT (N, NAT_SOURCE) TARGET DIAGNOSED_NAT_N_NAT_SOURCE_TARGET FRl9YR8LwNv Number of people living with HIV who know their status default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 DREAMS_GENERAL (N, DSD_NARRATIVE) TARGET: DREAMS DREAMS_GENERAL (N, DSD_NARRATIVE) TARGET DREAMS_GENERAL_N_DSD_NARRATIVE_TARGET nglH8tNt5cB default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 GEND_GBV (N, DSD_NARRATIVE) TARGET: GBV Care GEND_GBV (N, DSD_NARRATIVE) TARGET GEND_GBV_N_DSD_NARRATIVE_TARGET TCictYHddjB Number of people receiving post-GBV care default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 GEND_GBV (N, TA_NARRATIVE) TARGET: GBV Care GEND_GBV (N, TA_NARRATIVE) TARGET GEND_GBV_N_TA_NARRATIVE_TARGET t9Y2Ad63Zzc Number of people receiving post-GBV care default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 HTS_INDEX (N, DSD_NARRATIVE) TARGET: HTS Result HTS_INDEX (N, DSD_NARRATIVE) TARGET HTS_INDEX_N_DSD_NARRATIVE_TARGET gu2r5NnqJvt Target Number of individuals who were identified and tested using index testing services and received their results default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 HTS_INDEX (N, TA_NARRATIVE) TARGET: HTS Result HTS_INDEX (N, TA_NARRATIVE) TARGET HTS_INDEX_N_TA_NARRATIVE_TARGET qgy0uCYoMGC Target Number of individuals who were identified and tested using index testing services and received their results default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 HTS_RECENT (D, DSD_NARRATIVE) TARGET: HIV recency test HTS_RECENT (D, DSD_NARRATIVE) TARGET HTS_RECENT_D_DSD_NARRATIVE_TARGET pB4BUoRWvWB Target Number of newly diagnosed HIV-positive persons aged greater than or equal to >_ 15yrs with a test for recent infection result during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 HTS_RECENT (D, TA_NARRATIVE) TARGET: HIV recency test HTS_RECENT (D, TA_NARRATIVE) TARGET HTS_RECENT_D_TA_NARRATIVE_TARGET P3bf0wf1j0A Target Number of newly diagnosed HIV-positive persons aged greater than or equal to >_ 15yrs with a test for recent infection result during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 HTS_SELF (N, DSD_NARRATIVE) TARGET: HIV self test kits distributed HTS_SELF (N, DSD_NARRATIVE) TARGET HTS_SELF_N_DSD_NARRATIVE_TARGET EWoWnNYnSna Number of individual HIV self-test kits distributed. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 HTS_SELF (N, TA_NARRATIVE) TARGET: HIV self test kits distributed HTS_SELF (N, TA_NARRATIVE) TARGET HTS_SELF_N_TA_NARRATIVE_TARGET O5MDeE6XHFN Number of individual HIV self-test kits distributed. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 HTS_TST (N, DSD_NARRATIVE) TARGET: HTS received results HTS_TST (N, DSD_NARRATIVE) TARGET HTC_TST_N_DSD_NARRATIVE_TARGET AszwSRkm3Nl Number of individuals who received HTC services and received their test results during the PEPFAR reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 HTS_TST (N, TA_NARRATIVE) TARGET: HTS received results HTS_TST (N, TA_NARRATIVE) TARGET HTC_TST_N_TA_NARRATIVE_TARGET lBfHuLyTQVE Number of individuals who received HTC services and received their test results during the PEPFAR reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 IMPATT.KP_ESTIMATES_LIMITATIONS (NARRATIVE) IMPATT.KP_ESTIMATES_LIMITATIONS (NARRATIVE) IMPATT.KP_ESTIMATES_LIMITATIONS_NARRATIVE AGWqsUf3mbh default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 IMPATT.KP_ESTIMATES_SOURCE (NARRATIVE) IMPATT.KP_ESTIMATES_SOURCE (NARRATIVE) IMPATT.KP_ESTIMATES_SOURCE_NARRATIVE T9yFupyQSBD default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 IMPATT.PLHIV_LIMITATIONS (NARRATIVE) IMPATT.PLHIV_LIMITATIONS (NARRATIVE) IMPATT.PLHIV_LIMITATIONS qfsySB2b0j6 default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 IMPATT.PLHIV_SOURCE (NARRATIVE) IMPATT.PLHIV_SOURCE (NARRATIVE) IMPATT.PLHIV_SOURCE axVQSVAqwAu default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 IMPATT.POP_LIMITATIONS (NARRATIVE) IMPATT.POP_LIMITATIONS (NARRATIVE) IMPATT.POP_LIMITATIONS Z8z02qFMADa default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 IMPATT.POP_SOURCE (NARRATIVE) IMPATT.POP_SOURCE (NARRATIVE) IMPATT.POP_SOURCE absEOOivzp8 default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 IMPATT.PREVALENCE_LIMITATIONS (NARRATIVE) IMPATT.PREVALENCE_LIMITATIONS (NARRATIVE) IMPATT.PREVALENCE_LIMITATIONS PYQS5Ke7hxY default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 IMPATT.PREVALENCE_SOURCE (NARRATIVE) IMPATT.PREVALENCE_SOURCE (NARRATIVE) IMPATT.PREVALENCE_SOURCE I8heremjMjX default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 KP_MAT_NAT (N, NAT_JUSTIFICATION) TARGET: PWID on MAT KP_MAT_NAT (N, NAT_JUSTIFICATION) TARGET KP_MAT_N_NAT_JUSTIFICATION_TARGET tGBzez8We2m Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 KP_MAT_NAT (N, NAT_SOURCE) TARGET: PWID on MAT KP_MAT_NAT (N, NAT_SOURCE) TARGET KP_MAT_N_NAT_SOURCE_TARGET nxnrkNxZ5ux Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 KP_MAT (N, DSD_NARRATIVE) TARGET: PWID on MAT KP_MAT (N, DSD_NARRATIVE) TARGET KP_MAT_N_DSD_NARRATIVE_TARGET zfuQWlA4lxD Number of people who inject drugs (PWID) on MAT default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 KP_MAT (N, TA_NARRATIVE) TARGET: PWID on MAT KP_MAT (N, TA_NARRATIVE) TARGET KP_MAT_N_TA_NARRATIVE_TARGET qkHoqKFr9ad Number of people who inject drugs (PWID) on MAT default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 KP_PREV (N, DSD_NARRATIVE) TARGET: Key Pop Preventive KP_PREV (N, DSD_NARRATIVE) TARGET KP_PREV_N_DSD_NARRATIVE_TARGET hNIOQ3f7U6x Number of key populations reached with individual and/or small group level preventive interventions that are based on evidence and/or meet the minimum standards required default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 KP_PREV (N, TA_NARRATIVE) TARGET: Key Pop Preventive KP_PREV (N, TA_NARRATIVE) TARGET KP_PREV_N_TA_NARRATIVE_TARGET BqWXPRSNsOo Number of key populations reached with individual and/or small group level preventive interventions that are based on evidence and/or meet the minimum standards required default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 MER_OU (N, DSD_NARRATIVE) TARGET: OU Narratives MER_OU (N, DSD_NARRATIVE) TARGET MER_OU_N_DSD_NARRATIVE_TARGET EpUFHEkJcD5 default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 OVC_HIVSTAT (N, DSD_NARRATIVE) TARGET: OVC Disclosed Known HIV Status OVC_HIVSTAT (N, DSD_NARRATIVE) TARGET OVC_HIVSTAT_N_DSD_NARRATIVE_TARGET JYZldK0bQoW Number of OVC with HIV status reported to implementing partner (including status not reported). default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 OVC_HIVSTAT (N, TA_NARRATIVE) TARGET: OVC Disclosed Known HIV Status OVC_HIVSTAT (N, TA_NARRATIVE) TARGET OVC_HIVSTAT_N_TA_NARRATIVE_TARGET n91nOska2Ss Number of OVC with HIV status reported to implementing partner (including status not reported). default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 OVC_SERV (N, DSD_NARRATIVE) TARGET: Beneficiaries Served OVC_SERV (N, DSD_NARRATIVE) TARGET OVC_SERV_N_DSD_NARRATIVE_TARGET hENDDXsXSYv Number of active beneficiaries served by PEPFAR programs for children and families affected by HIV/AIDS. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 OVC_SERV (N, TA_NARRATIVE) TARGET: Beneficiaries Served OVC_SERV (N, TA_NARRATIVE) TARGET OVC_SERV_N_TA_NARRATIVE_TARGET yCxB0DAlvgi Number of active beneficiaries served by PEPFAR programs for children and families affected by HIV/AIDS. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_ART_NAT (N, NAT_JUSTIFICATION) TARGET: ART PMTCT_ART_NAT (N, NAT_JUSTIFICATION) TARGET PMTCT_ARV_N_NAT_JUSTIFICATION_TARGET E0WmD74q3vd Number of HIV-positive pregnant women who received ARVs to reduce risk of mother-to-child transmission during pregnancy default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_ART_NAT (N, NAT_SOURCE) TARGET: ART PMTCT_ART_NAT (N, NAT_SOURCE) TARGET PMTCT_ARV_N_NAT_SOURCE_TARGET SmzENp3Ga2M Number of HIV-positive pregnant women who received ARVs to reduce risk of mother-to-child transmission during pregnancy default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_ART (N, DSD_NARRATIVE) TARGET: ART PMTCT_ART (N, DSD_NARRATIVE) TARGET PMTCT_ARV_N_DSD_NARRATIVE_TARGET g8gm86GMsnf Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission during pregnancy. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_ART (N, TA_NARRATIVE) TARGET: ART PMTCT_ART (N, TA_NARRATIVE) TARGET PMTCT_ARV_N_TA_NARRATIVE_TARGET FTAK0l4GoxR Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission during pregnancy. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_EID (N, DSD_NARRATIVE) TARGET: Infant Testing PMTCT_EID (N, DSD_NARRATIVE) TARGET PMTCT_EID_N_DSD_NARRATIVE_TARGET MwIW11C0WJ0 Number of infants who had a virologic HIV test within 12 months of birth during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_EID (N, TA_NARRATIVE) TARGET: Infant Testing PMTCT_EID (N, TA_NARRATIVE) TARGET PMTCT_EID_N_TA_NARRATIVE_TARGET gXDT7AaAWS1 Number of infants who had a virologic HIV test within 12 months of birth during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_STAT_NAT (N, NAT_JUSTIFICATION) TARGET: Known Results PMTCT_STAT_NAT (N, NAT_JUSTIFICATION) TARGET PMTCT_STAT_N_NAT_JUSTIFICATION_TARGET ZMrP8hwILjt Number of pregnant women with known HIV status (includes those who already knew their HIV status prior to ANC) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_STAT_NAT (N, NAT_SOURCE) TARGET: Known Results PMTCT_STAT_NAT (N, NAT_SOURCE) TARGET PMTCT_STAT_N_NAT_SOURCE_TARGET tTUZHln4ysW Number of pregnant women with known HIV status (includes those who already knew their HIV status prior to ANC) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_STAT (N, DSD_NARRATIVE) TARGET: Known Results PMTCT_STAT (N, DSD_NARRATIVE) TARGET PMTCT_STAT_N_DSD_NARRATIVE_TARGET M2mpyosW22O Number of pregnant women with known HIV status (includes those who already knew their HIV status prior to ANC) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PMTCT_STAT (N, TA_NARRATIVE) TARGET: Known Results PMTCT_STAT (N, TA_NARRATIVE) TARGET PMTCT_STAT_N_TA_NARRATIVE_TARGET LiyIXa8g9Jp Number of pregnant women with known HIV status (includes those who already knew their HIV status prior to ANC) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PP_PREV (N, DSD_NARRATIVE) TARGET: HIV Prevention Program PP_PREV (N, DSD_NARRATIVE) TARGET PP_PREV_N_DSD_NARRATIVE_TARGET OgfvNuoHrE9 Number of each priority population who completed a standardized HIV prevention program including the specified minimum components during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PP_PREV (N, TA_NARRATIVE) TARGET: HIV Prevention Program PP_PREV (N, TA_NARRATIVE) TARGET PP_PREV_N_TA_NARRATIVE_TARGET MIE0LpWuOzE Number of each priority population who completed a standardized HIV prevention program including the specified minimum components during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PrEP_CURR (N, DSD_NARRATIVE) TARGET: Receiving PrEP PrEP_CURR (N, DSD_NARRATIVE) TARGET PrEP_CURR_N_DSD_NARRATIVE_TARGET ycOETT18OVi Target Number of individuals, including those newly enrolled, receiving oral PrEP during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PrEP_CURR (N, TA_NARRATIVE) TARGET: Receiving PrEP PrEP_CURR (N, TA_NARRATIVE) TARGET PrEP_CURR_N_TA_NARRATIVE_TARGET VKcDhv9JrfS Target Number of individuals, including those newly enrolled, receiving oral PrEP during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PrEP_NEW (N, DSD_NARRATIVE) TARGET: Newly Enrolled PrEP PrEP_NEW (N, DSD_NARRATIVE) TARGET PrEP_NEW_N_DSD_NARRATIVE_TARGET MfIObZcfn3Y Number of individuals who have been newly enrolled on antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 PrEP_NEW (N, TA_NARRATIVE) TARGET: Newly Enrolled PrEP PrEP_NEW (N, TA_NARRATIVE) TARGET PrEP_NEW_N_TA_NARRATIVE_TARGET fH43Ve77RMl Number of individuals who have been newly enrolled on antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TB_ART (N, DSD_NARRATIVE) TARGET: TB/HIV on ART TB_ART (N, DSD_NARRATIVE) TARGET TB_ART_N_DSD_NARRATIVE_TARGET diaXaUfnYGm Number of TB cases with documented HIV-positive status who start or continue ART during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TB_ART (N, TA_NARRATIVE) TARGET: TB/HIV on ART TB_ART (N, TA_NARRATIVE) TARGET TB_ART_N_TA_NARRATIVE_TARGET G7fse5VeFkA Number of TB cases with documented HIV-positive status who start or continue ART during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TB_PREV (N, DSD_NARRATIVE) TARGET: IPT TB_PREV (N, DSD_NARRATIVE) TARGET TB_PREV_N_DSD_NARRATIVE_TARGET nNVVPJ4HBaj The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TB_PREV (N, TA_NARRATIVE) TARGET: IPT TB_PREV (N, TA_NARRATIVE) TARGET TB_PREV_N_TA_NARRATIVE_TARGET i1yJ9hH8m4K The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TB_STAT (N, DSD_NARRATIVE) TARGET: New/Relapsed TB with HIV TB_STAT (N, DSD_NARRATIVE) TARGET TB_STAT_N_DSD_NARRATIVE_TARGET bfbutyZWFef Number of registered new and relapsed TB cases with documented HIV status, during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TB_STAT (N, TA_NARRATIVE) TARGET: New/Relapsed TB with HIV TB_STAT (N, TA_NARRATIVE) TARGET TB_STAT_N_TA_NARRATIVE_TARGET B53yDnKSgjQ Number of registered new and relapsed TB cases with documented HIV status, during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_CURR_NAT (N, NAT_JUSTIFICATION) TARGET: Receiving ART TX_CURR_NAT (N, NAT_JUSTIFICATION) TARGET TX_CURR_N_NAT_JUSTIFICATION_TARGET okJOviBaoYH Number of adults and children currently receiving antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_CURR_NAT (N, NAT_SOURCE) TARGET: Receiving ART TX_CURR_NAT (N, NAT_SOURCE) TARGET TX_CURR_N_NAT_SOURCE_TARGET QFWrSbAXtKQ Number of adults and children currently receiving antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_CURR (N, DSD_NARRATIVE) TARGET: Receiving ART TX_CURR (N, DSD_NARRATIVE) TARGET TX_CURR_N_DSD_NARRATIVE_TARGET l9zJ4agOaPL Number of adults and children currently receiving antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_CURR (N, TA_NARRATIVE) TARGET: Receiving ART TX_CURR (N, TA_NARRATIVE) TARGET TX_CURR_N_TA_NARRATIVE_TARGET c3gSdCDhSX2 Number of adults and children currently receiving antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_NEW (N, DSD_NARRATIVE) TARGET: New on ART TX_NEW (N, DSD_NARRATIVE) TARGET TX_NEW_N_DSD_NARRATIVE_TARGET AiqC7fMorHl Number of adults and children newly enrolled on antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_NEW (N, TA_NARRATIVE) TARGET: New on ART TX_NEW (N, TA_NARRATIVE) TARGET TX_NEW_N_TA_NARRATIVE_TARGET PJc5gmdiYIs Number of adults and children newly enrolled on antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_PVLS (N, DSD_NARRATIVE) TARGET: 12 Months Viral Load < 1000 TX_PVLS (N, DSD_NARRATIVE) TARGET TX_PVLS_N_DSD_NARRATIVE_TARGET M8nGzNYjZrE Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and/or supporting laboratory results within the past 12 months. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_PVLS (N, TA_NARRATIVE) TARGET: 12 Months Viral Load < 1000 TX_PVLS (N, TA_NARRATIVE) TARGET TX_PVLS_N_TA_NARRATIVE_TARGET S5l4WZcMHWB Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and/or supporting laboratory results within the past 12 months. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_TB (N, DSD_NARRATIVE) TARGET: TB Screening TX_TB (N, DSD_NARRATIVE) TARGET TX_TB_N_DSD_NARRATIVE_TARGET fP9C3DcLQrW Number of ART patients who were started on TB treatment during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 TX_TB (N, TA_NARRATIVE) TARGET: TB Screening TX_TB (N, TA_NARRATIVE) TARGET TX_TB_N_TA_NARRATIVE_TARGET vOsMaB8IOvP Number of ART patients who were started on TB treatment during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 VL_SUPPRESSION_NAT (N, NAT_JUSTIFICATION) TARGET: Suppressed Viral Load VL_SUPPRESSION_NAT (N, NAT_JUSTIFICATION) TARGET VL_SUPPRESSION_NAT_N_NAT_JUSTIFICATION_TARGET rDmpKiFdQf5 Number of adults and children receiving antiretroviral therapy in the reporting period with suppressed viral load (i.e. ≤1000 copies) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 VL_SUPPRESSION_NAT (N, NAT_SOURCE) TARGET: Suppressed Viral Load VL_SUPPRESSION_NAT (N, NAT_SOURCE) TARGET VL_SUPPRESSION_NAT_N_NAT_SOURCE_TARGET WinwiB53srG Number of adults and children receiving antiretroviral therapy in the reporting period with suppressed viral load (i.e. ≤1000 copies) default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 VMMC_CIRC_NAT (N, NAT_JUSTIFICATION) TARGET: Voluntary Circumcised VMMC_CIRC_NAT (N, NAT_JUSTIFICATION) TARGET VMMC_CIRC_N_NAT_JUSTIFICATION_TARGET Cmdrwp1PB5H Number of males circumcised during the reporting period according to national standards default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 VMMC_CIRC_NAT (N, NAT_SOURCE) TARGET: Voluntary Circumcised VMMC_CIRC_NAT (N, NAT_SOURCE) TARGET VMMC_CIRC_N_NAT_SOURCE_TARGET ojwjJhlAWMq Number of males circumcised during the reporting period according to national standards default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 VMMC_CIRC (N, DSD_NARRATIVE) TARGET: Voluntary Circumcised VMMC_CIRC (N, DSD_NARRATIVE) TARGET VMMC_CIRC_N_DSD_NARRATIVE_TARGET JlUZDARfngB Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the preporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 VMMC_CIRC (N, TA_NARRATIVE) TARGET: Voluntary Circumcised VMMC_CIRC (N, TA_NARRATIVE) TARGET VMMC_CIRC_N_TA_NARRATIVE_TARGET qb8x25GrK3L Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the preporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 VMMC_TOTALCIRC_NAT (N, NAT_JUSTIFICATION) TARGET: Voluntary Circumcised VMMC_TOTALCIRC_NAT (N, NAT_JUSTIFICATION) TARGET VMMC_TOTALCIRC_NAT_N_NAT_JUSTIFICATION_TARGET jA45CAfrNQb Total number of men ever circumcised default HllvX50cXC0 HllvX50cXC0
Host Country Targets: Narratives (USG) FY2020 VMMC_TOTALCIRC_NAT (N, NAT_SOURCE) TARGET: Voluntary Circumcised VMMC_TOTALCIRC_NAT (N, NAT_SOURCE) TARGET VMMC_TOTALCIRC_NAT_N_NAT_SOURCE_TARGET kFKyrdf8OFI Total number of men ever circumcised default HllvX50cXC0 HllvX50cXC0